Toxic Ingestion Clinical Pathway — Emergency Department, ICU and Inpatient
Toxic Ingestion Clinical Pathway — Emergency Department, ICU and Inpatient
Enhanced Elimination
Consult Poison Control Center to determine suitability, timing, and dosing.
Urinary Alkalinization
- Indication
- Weak acids
- Example Substances
- Salicylates
- Rarely: chlorpropamide, phenobarbital
- Mechanism
- Prevents reabsorption of substance in kidneys enhancing urinary excretion
- Administration
- IV sodium bicarbonate
- Poison Control Center consultation available for precise IV fluid composition and dosing advice
- Comments
- Can cause hypokalemia
- Requires close electrolyte monitoring
Multiple Dose Activated Charcoal
- Indications
- Rarely recommended, consider for substances with:
- Enterohepatic recirculation and/or
- Bind strongly with activated charcoal
- Low volume of distribution and low protein binding
- Rarely recommended, consider for substances with:
- Example Substances
- Carbamazepine
- Phenobarbital
- Salicylates
- Theophylline
- Mechanism
- Interrupts enterohepatic circulation
- “Intestinal dialysis” effect: pulls substances along a concentration gradient from intestinal vasculature into the intestinal lumen to be bound to activated charcoal
- Administration
- PO or NG
- Repeated in 2-4 hrs
- Re-evaluation after 2-3 doses
- Comments
- Aspiration, emesis risk with administration
- Requires intact peristalsis
Hemodialysis
- Indications
- Small molecular weight compounds with low volume of distribution and low protein binding
- Significant, reversible metabolic disturbances associated with poisoning
- Example Substances
- Lithium, salicylates, theophylline, toxic alcohols
- Refer to EXTRIP list for additional substances
- Mechanism
- Removal via diffusion and convection through dialysis membrane
- Administration
- Intermittent versus CRRT
- Comments
- Initiate timely consultation with nephrology and PICU for management/disposition